OOIR: Observatory of International Research

Papers

(The TQCC of Breast Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	87
Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial	82
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	57
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer	42
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study	39
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	36
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	32
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	27
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line	26
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances	24
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer	21
Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma	21
Factors associated with post acute care utilization after mastectomy for breast cancer patients	20
The role of C1orf50 in breast cancer progression and prognosis	19
Emerging roles of KIR2DL4 in cancer immunotherapy	18
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions — a first large-scale multi-institutional clinical trial in Japan	18
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan	17
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	16
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	16
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	15
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	15
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study	14
SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	14
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	14
Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutio	13

Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	13
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	13
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	13
Relevance of the MHC region for breast cancer susceptibility in Asians	13
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer	13
Prospective randomized-controlled trial: efficacy of 37 °C-preheated thermoplastic elastomer (TPE) bolus in postoperative radiotherapy for breast cancer patients	13
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan	13
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	13
Glutaminase (GLS1) gene expression in primary breast cancer	13
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	12
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a	12
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	12
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	12
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	11
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	11
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer	11
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy	11
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	11
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer	11
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1	11
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	10
Breast cancer screening guidelines: discrepancies raise concerns about validity	10
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review	10
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis	10
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2− advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis	10
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	9
Association between preoperative grip strength and postoperative upper extremity impairments in patients with breast cancer: a retrospective cohort study	9
Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions	9
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status	9
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study	9
Impact of artificial intelligence in breast cancer screening with mammography	9
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast	9
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)	9
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models	9
Chemotherapy and cognition: a promising start, but mechanistic clarity still needed	9
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer	9
Color differences of skin paddles using the free flap for autologous breast reconstruction in Asian patients	9
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells	9
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes	9
Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer	9
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein	9
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol	9
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiatio	9
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	9
The impact of specialist palliative care on healthcare utilization among patients with breast cancer: a nationwide register-based cohort study	8
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen r	8
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	8
Performance analysis of screening mammography in Asian women under 40 years	8
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes	8
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	8

Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	8
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	8
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	8
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	8
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	8
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	8
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow	7
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	7
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	7
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort study	7
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity	7
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	7
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome	7
Correction: The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathway	7
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	7
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	7
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results	7
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties	7
Patient satisfaction on prescription refill systems for breast cancer patients in Japan using a digital self-administered survey	7
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	7
Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02)	7
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	6
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	6
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	6
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	6
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	6
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	6
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	6
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	6
Timing of postmastectomy radiation therapy in two-stage expander/implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese breast cancer society clinical practic	6
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	6
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	6
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	6
Characterization of gut microbiota dysbiosis in breast cancer patients	6
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	6
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	6
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	6
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	6
Management of nausea and vomiting induced by antibody–drug conjugates	6
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	6
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	6
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	6
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	6
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	6
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	6
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women	6
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	6
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	6
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	6